China Tests a Gene-and-Drug Switch for Brain Circuits in HumansHOT
A Chinese team has run the world's first human trial of chemogenetic neuromodulation, pairing gene therapy with a small-molecule drug so doctors can dial nerve activity up or down. The results appeared in a major medical journal, with outside reviewers calling the adjustable dose the key advance.